Healthcare Utilization of Patients with Systemic Lupus Erythematosus In a US Medicaid Population

被引:0
|
作者
Song, Xue [1 ]
Kan, Hong [2 ]
Johnson, Barbara H. [3 ]
Bechtel, Benno [4 ]
O'Sullivan, Donna [3 ]
Molta, Charles T. [5 ]
机构
[1] Thomson Reuters, Cambridge, MA USA
[2] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
[3] Thomson Reuters, Washington, DC USA
[4] GlaxoSmithKline Inc, Munich, Germany
[5] GlaxoSmithKline Inc, Philadelphia, PA USA
来源
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
917
引用
下载
收藏
页码:S360 / S361
页数:2
相关论文
共 50 条
  • [21] Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States
    Murimi-Worstell, Irene B.
    Lin, Dora H.
    Kan, Hong
    Tierce, Jonothan
    Wang, Xia
    Nab, Henk
    Desta, Barnabas
    Alexander, G. Caleb
    Hammond, Edward R.
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (03) : 385 - 393
  • [22] Identification of patients with systemic lupus erythematosus in administrative healthcare databases
    Hanly, J. G.
    Thompson, K.
    Skedgel, C.
    LUPUS, 2014, 23 (13) : 1377 - 1382
  • [23] Gender Disparities in Hospitalization Outcomes and Healthcare Utilization Among Patients with Systemic Lupus Erythematosus in the United States
    Uwumiro, Fidelis
    Okpujie, Victory O.
    Osemwota, Osasumwen
    Okafor, Nnenna E.
    Otu, Michael I.
    Borowa, Azabi
    Ezerioha, Pascal
    Tejere, Ejiroghene
    Alemenzohu, Hillary
    Bojerenu, Michael M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [24] A REAL-WORLD STUDY OF HEALTHCARE RESOURCE UTILIZATION AND COSTS FOR SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS IN TAIWAN
    Tang, C. H.
    Chang, Y. S.
    Ng, K. J.
    Chuang, P. Y.
    Furnback, W.
    Wang, B.
    Wei, A.
    Treuer, T.
    VALUE IN HEALTH, 2022, 25 (07) : S599 - S600
  • [25] Prevalence of Diagnosed Systemic Lupus Erythematosus (SLE), Patient Healthcare Utilization and Characteristics by Major Health Insurance Types in the US
    Wang, Yiting
    Hester, Laura
    Lofland, Jennifer
    Rose, Shawn
    Karyekar, Chetan
    Kern, Dave
    Blacketer, Margaret
    Davis, Kourtney
    Shields-Tuttle, Kimberly
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [26] Healthcare Resource Utilization and Costs in Patients with Systemic Lupus Erythematosus before and after Initiating Treatment with Intravenous Belimumab: A US Claims Database Analysis
    Bell, Christopher F.
    Priest, Julie
    Stott-Miller, Marni
    Kan, Hong
    Amelio, Justyna
    Song, Xue
    Limone, Brendan
    Noxon, Virginia
    Costenbader, Karen H.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [27] Long-Term Medical Costs and Resource Utilization in Systemic Lupus Erythematosus and Lupus Nephritis: A Five-Year Analysis of a Large Medicaid Population
    Li, Tracy
    Carls, Ginger Smith
    Panopalis, Pantelis
    Wang, Sara
    Gibson, Teresa B.
    Goetzel, Ron Z.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (06): : 755 - 763
  • [28] Comparative Rates of Osteoporotic Fractures Among US Medicaid Enrollees with and without Systemic Lupus Erythematosus
    Tedeschi, Sara K.
    Pan, Beatrice
    Guan, Hongshu
    Kim, Seoyoung C.
    Solomon, Daniel H.
    Costenbader, Karen H.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [29] MORTALITY RATES AMONG US MEDICAID RECIPIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, 2000-2006
    Gomez-Puerta, J. A.
    Feldman, C. H.
    Liu, J.
    Alarcon, G. S.
    Fischer, M. A.
    Costenbader, K. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 556 - 556
  • [30] Atrial Fibrillation/flutter Hospitalizations among US Medicaid Recipients with and without Systemic Lupus Erythematosus
    Chen, Sarah K.
    Barbhaiya, Medha
    Solomon, Daniel H.
    Guan, Hongshu
    Yoshida, Kazuki
    Feldman, Candace H.
    Everett, Brendan M.
    Costenbader, Karen H.
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (09) : 1359 - 1365